Results 151 to 160 of about 153,345 (297)

Kinetics of Conversion of Prothrombin to Thrombin by Biological Activators

, 1963
N. Raphael Shulman, John Z. Hearon
openalex   +1 more source

A Comparative Study of Three Methods Measuring Prothrombin Time [PDF]

, 1968
A Gudaitis, Robert M. Donauer
openalex   +1 more source

The transition of prothrombin to thrombin

Journal of Thrombosis and Haemostasis, 2013
S. Krishnaswamy
semanticscholar   +1 more source

Laboratory practice on detection of antiphospholipid antibodies: UK NEQAS blood coagulation survey—2024

British Journal of Haematology, EarlyView.
Deepa J. Arachchillage, Mike Laffan, Will Lester, Steve Kitchen, Ian Jennings   +4 more
wiley   +1 more source

Identifying Professional Responsibilities and Designing the Optimal Curriculum for Haemophilia Nurses in Spain: A Round Table Discussion

Haemophilia, EarlyView.
ABSTRACT Introduction There is a lack of consensus on professional competencies or educational requirements needed for registered nurses working with haemophilia patients (namely, haemophilia nurses) in thrombosis and haemostasis units in Spain. Their role is not officially recognised in many healthcare systems (HCS), including Spain.
Sara García‐Barcenilla, Montserrat Rambla Pérez, Noelia Pérez, Alfonso Castro Blanco, Anna Diaz, Carmen Fernandez Sarmiento, Eva Álvarez Martínez, María Dolores de Dios, María del Carmen García Martínez, María Teresa Torres, Mercè Triquell Garrell, Nuria Caballero Mencía, María Antonia Fernández   +12 more
wiley   +1 more source

Effect of carbamazepine and levetiracetam on coagulation parameters: Prothrombin time, activated partial thromboplastin time, D-dimer, and fibrinogen levels. [PDF]

J Med Biochem
Li J, Zhong C, Bian G.
europepmc   +1 more source

Effectiveness and safety of antithrombin for treatment of portal vein thrombosis: Nationwide prospective surveillance of 4 years of clinical experience in Japan

Hepatology Research, EarlyView.
Abstract Aim Antithrombin (AT), a plasma protein with anticoagulant properties, has a long‐standing medical history, primarily for treatment of congenital AT deficiency. Accumulated clinical experiences suggest AT is a potential anticoagulant for thrombotic diseases. This study aimed to clarify the effectiveness, safety, and clinical significance of AT
Shoichi Matsutani, Makoto Arakawa, Susumu Nakano   +2 more
wiley   +1 more source

Developing a molecular diagnostic model for heatstroke-induced coagulopathy: a proteomics and metabolomics approach. [PDF]

Front Mol Biosci
Zeng Q, Lin Q, He L, Zhong L, Zhou Y, Deng X, Zhang N, Song Q, Song J.   +8 more
europepmc   +1 more source

Correlated Responses of Blood Coagulation and Prothrombin Times to Selection for Body Weight

, 1969
S.C. Mohapatra, P.B. Siegel
openalex   +1 more source

Continuous Intravenous Infusion of Hepatocyte Growth Factor Promotes the Development of a Fibrolytic Phenotype in Hepatic Macrophages and Stellate Cells in a Rat Model of Bile Duct Ligation

Hepatology Research, EarlyView.
This study demonstrates that continuous intravenous infusion of hepatocyte growth factor can significantly reduce liver fibrosis in rats. This treatment promotes hepatocyte regeneration and reduces harmful inflammation, offering promising potential as a therapy for liver cirrhosis in humans. ABSTRACT Aim Liver cirrhosis is a severe condition that often
Oki Taniyama, Kotaro Kumagai, Shuji Kanmura, Yuko Nakamura, Hiromi Eguchi, Miho Uehara, Kyoko Meguro, Ai Toyodome, Sho Ijuin, Haruka Sakae, Kazuaki Tabu, Kohei Oda, Seiichi Mawatari, Keisuke Yano, Satoshi Ieiri, Akio Ido   +15 more
wiley   +1 more source